Loading clinical trials...
Loading clinical trials...
This is a phase IV multicenter trial to evaluate the pharmacoeconomic (PE) impact of crizotinib and its companion diagnostic test used in a real-life setting in advanced ALK-positive non-small cell lu...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
PeriPharm
Collaborators
NCT07144280 · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, and more
NCT07250477 · Non-small Cell Lung Cancer Stage IIIC, Non-small Cell Lung Cancer Stage IV, and more
NCT02622581 · Metastatic Non-small Cell Lung Cancer (NSCLC), Non-small Cell Lung Cancer Metastatic, and more
NCT06517953 · Non-small Cell Lung Cancer Metastatic, EGFR G719X, and more
NCT04163432 · Non-Small Cell Lung Cancer Metastatic
The Ottawa Hospital
Ottawa, Ontario
Princess Margaret Hospital
Toronto, Ontario
CSSS de Rimouski-Neigette
Rimouski, Quebec
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions